Human papillomavirus vaccination for men: What is new about this issue in South America?
Marcos Roberto Tovani Palone
University of Sao Paulo, Brazil
: J Chem Appl Chem Eng
Abstract
Human papillomavirus (HPV) infection is a major health problem that affects young people and adults. At present, thousands of people are infected by HPV in various parts of the world. In men, this infection can result in the development of cancers of the penis, oropharynx and anus. Surprisingly, in 2017, both Brazil and Argentina started to offer HPV vaccination for boys and/or male adolescents in their national vaccination calendars. Therefore, they were the first countries of South America to offer this vaccination for males as a preventive measure officially recommended by the Ministry of Health. However, so far, there is very few information about this issue in the literature. Thus, I am conducting a research study on the implementation of HPV vaccination for males in these two countries, with special focus on public health aspects. Certainly the findings of such study will contribute to important advances in this field.
Biography
Marcos Roberto Tovani Palone has completed his MSc from the Hospital for Rehabilitation of Craniofacial Anomalies, University of Sao Paulo, Brazil, and currently he is pursuing PhD in Experimental Pathology from Ribeirao Preto Medical School, University of Sao Paulo, Brazil, under the coordination of Doctor Leandra Náira Zambelli Ramalho. He is a DDS and, moreover, specialist in pediatric dentistry, syndromes and craniofacial anomalies, and health management. His main research interests are pediatric pathology, cleft lip and palate, dentistry and public health. He has published more than 37 papers in reputed journals and has been serving as an editorial board member of 30 journals.
E-mail: marcos_palone@hotmail.com
